Survey shows food allergy prevalence in US children rose from 4.0% to 6.5% over 11 years
Survey finds more U.S. children reported having food allergies over an 11-year period
A US observational survey of children aged 0-17 years found the percentage reporting a food or digestive allergy in the past 12 months incre…
Reports of childhood food allergies in the U.S. rose from 4.0% in 2007 to 6.5% in 2018, showing more kids affected over 11 years.
Survey finds higher current asthma prevalence among US adult women compared to men
Survey finds adult women in the US more likely to have asthma than men
A US National Health Interview Survey analysis of adults aged ≥18 years found women were more likely than men to currently have asthma.
A 2017-2018 national survey shows adult women in the US are more likely than men to currently have asthma.
Surveillance reports anaphylaxis cases after first Moderna COVID-19 vaccine doses in US
What happens when people have severe allergic reactions to the Moderna vaccine?
A US surveillance report describes cases of anaphylaxis following first doses of the Moderna COVID-19 vaccine.
Health officials report severe allergic reactions, including anaphylaxis, after people received their first dose of the Moderna COVID-19 vac…
Surveillance report tracks progress in reducing deaths among persons with diagnosed HIV in the US
Are we making progress in reducing deaths among people with HIV?
A US surveillance report monitored progress toward reducing deaths among persons with diagnosed HIV infection.
Tracking deaths among people with diagnosed HIV across the U.S. helps monitor progress toward longer, healthier lives for this community.
Advisory committee recommends resuming Janssen COVID-19 vaccination for adults, citing benefits over risks
Health officials update recommendations for Johnson & Johnson COVID-19 vaccine
A U.S. advisory committee issued updated recommendations for the Janssen COVID-19 vaccine for persons aged ≥18 years.
Health officials keep the Johnson & Johnson COVID-19 vaccine available for adults but add a warning about rare clotting risks for women aged…
2022 Adult Immunization Schedule Updated for U.S. Adults Aged 19 Years or Older
Health officials update recommended adult vaccination schedule for 2022
A guideline report describes changes to the 2022 adult immunization schedule for U.S.
Health officials released the updated 2022 vaccination schedule for adults aged 19 and older, outlining when to get flu, COVID-19, and shing…
CDC and AAP update 2023 immunization schedule for children and adolescents
What's new in the 2023 childhood vaccine schedule?
The CDC and AAP have issued updated immunization recommendations for children and adolescents aged 18 years or younger in the United States.
The 2023 childhood vaccine schedule is now available to help doctors and parents protect kids from serious illnesses like measles and whoopi…
ACIP Recommends JYNNEOS Vaccine for Occupational Orthopoxvirus Exposure Risk
U.S. health advisors recommend monkeypox vaccine for certain at-risk workers
The Advisory Committee on Immunization Practices (ACIP) issued a recommendation for preexposure vaccination with JYNNEOS (Smallpox and Monke…
U.S. health advisors now recommend the JYNNEOS vaccine for lab workers and healthcare staff at risk of exposure to monkeypox, smallpox, and …
PRIORIX vaccine recommended for measles, mumps, and rubella protection in the United States
CDC panel recommends PRIORIX vaccine for measles, mumps, and rubella protection
A recommendation for the use of PRIORIX vaccination against measles, mumps, and rubella has been issued in the United States.
A CDC advisory panel now recommends the PRIORIX vaccine as a new option alongside the familiar MMR shot for measles, mumps, and rubella prot…
ACIP Updates Recommendations for Pneumococcal Vaccine Use in U.S. Adults
Health Panel Updates Pneumococcal Vaccine Recommendations for U.S. Adults
The Advisory Committee on Immunization Practices (ACIP) has issued updated recommendations for pneumococcal vaccine use in U.S.
New U.S. guidelines now recommend specific pneumococcal vaccines for all adults aged 19 and older to protect against pneumonia and meningiti…
HIV-2 diagnoses remain low in the United States, differentiation test use studied
HIV-2 diagnoses remain low in the United States, report finds
A U.S. report on trends in HIV-2 diagnoses and HIV-1/HIV-2 differentiation test use found diagnoses of HIV-2 remain low.
HIV-2 diagnoses stay low in the U.S., but current testing methods could be updated to work better.
Updated immunization schedule for children and adolescents released in the United States
Health officials update recommended vaccine schedule for children and adolescents
A new guideline provides the recommended immunization schedule for children and adolescents aged 18 years or younger in the United States.
New U.S. vaccine schedules for kids and teens now guide doctors on the best timing for shots from birth through age 18.